David J Moss - 18 Nov 2025 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Chief Executive Officer, Director
Signature
/s/ David Moss
Issuer symbol
INMB
Transactions as of
18 Nov 2025
Net transactions value
$0
Form type
4
Filing time
18 Nov 2025, 17:31:03 UTC
Previous filing
09 Dec 2024
Next filing
02 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Moss David J Chief Executive Officer, Director C/O INMUNE BIO INC., 225 NE MIZNER BLVD., SUITE 640, BOCA RATON /s/ David Moss 18 Nov 2025 0001421930

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Stock Option (right to buy) Disposed to Issuer -400,000 -100% 0 18 Nov 2025 Common Stock 400,000 $7.80 Direct F1, F2
transaction INMB Stock Option (right to buy) Award +400,000 400,000 18 Nov 2025 Common Stock 400,000 $1.50 Direct F1, F2
transaction INMB Stock Option (right to buy) Disposed to Issuer -59,337 -100% 0 18 Nov 2025 Common Stock 59,337 $24.82 Direct F1, F2
transaction INMB Stock Option (right to buy) Award +59,337 59,337 18 Nov 2025 Common Stock 59,337 $1.50 Direct F1, F2
transaction INMB Stock Option (right to buy) Disposed to Issuer -275,000 -100% 0 18 Nov 2025 Common Stock 275,000 $3.91 Direct F1, F2
transaction INMB Stock Option (right to buy) Award +275,000 275,000 18 Nov 2025 Common Stock 275,000 $1.50 Direct F1, F2
transaction INMB Stock Option (right to buy) Disposed to Issuer -70,663 -100% 0 18 Nov 2025 Common Stock 70,663 $17.49 Direct F1, F2
transaction INMB Stock Option (right to buy) Award +70,663 70,663 18 Nov 2025 Common Stock 70,663 $1.50 Direct F1, F2
transaction INMB Stock Option (right to buy) Disposed to Issuer -160,000 -100% 0 18 Nov 2025 Common Stock 160,000 $9.74 Direct F1, F2
transaction INMB Stock Option (right to buy) Award +160,000 160,000 18 Nov 2025 Common Stock 160,000 $1.50 Direct F1, F2
transaction INMB Stock Option (right to buy) Disposed to Issuer -130,000 -100% 0 18 Nov 2025 Common Stock 130,000 $7.92 Direct F1, F2
transaction INMB Stock Option (right to buy) Award +130,000 130,000 18 Nov 2025 Common Stock 130,000 $1.50 Direct F1, F2
transaction INMB Stock Option (right to buy) Disposed to Issuer -223,000 -100% 0 18 Nov 2025 Common Stock 223,000 $5.05 Direct F1, F2
transaction INMB Stock Option (right to buy) Award +223,000 223,000 18 Nov 2025 Common Stock 223,000 $1.50 Direct F1, F2
transaction INMB Stock Option (right to buy) Disposed to Issuer -160,000 -100% 0 18 Nov 2025 Common Stock 160,000 $9.92 Direct F1, F2
transaction INMB Stock Option (right to buy) Award +160,000 160,000 18 Nov 2025 Common Stock 160,000 $1.50 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective as of November 18, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2017 Stock Incentive Plan (the "2017 Plan"), 2019 Stock Incentive Plan (the "2019 Plan"), and Second Amended and Restated 2021 Stock Incentive Plan (as may be amended, restated or otherwise modified from time to time in accordance with its terms, the "2021 Plan") , which reduced the per share exercise price of each Repriced Option to $1.50, representing the closing price of the Issuer's common stock on The Nasdaq Capital Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.
F2 This stock option award was issued pursuant to the 2017 Plan, 2019 Plan and/or the 2021 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.